Results 261 to 270 of about 399,014 (392)

SiO2@Benzothiazole‐Cl@Fc as an Efficient Heterogeneous Catalyst for the Synthesis of 1,3,5‐Trisubstituted Pyrazoles by A3 Coupling

ChemistryOpen, EarlyView.
This research introduces the preparation and analysis of a newly heterogeneous catalyst developed silica nanospheres supporting a ferrocene‐containing ionic liquid (SiO2@Benzothiazole‐Cl@Fc) for the A3 coupling reaction. The catalyst facilitates the efficient synthesis of 1,3,5‐trisubstituted pyrazoles from aromatic hydrazides, aldehydes, and aromatic ...
Fadhil Faez Sead, Vicky Jain, Roopashree R, Aditya Kashyap, Suman Saini, Girish Chandra Sharma, Pushpa Negi Bhakuni, Mosstafa Kazemi, Ramin Javahershenas   +8 more
wiley   +1 more source

Comprehensive Chemical Analysis of the Methyl 3-Nitrogen-2,3-Dideoxysaccharides Derivatives with d-<i>ribo</i>-Configuration: Synthesis, Reactivity of HIV-1 Reverse Transcriptase Inhibitors. [PDF]

J Phys Chem B
Dąbrowska AM, Kaźmierkiewicz R, Barabaś-Lepak AM, Biedulska M, Chylewska A.   +4 more
europepmc   +1 more source

Comparing albuvirtide plus ritonavir-boosted lopinavir regimen to two nucleotide reverse transcriptase inhibitors plus ritonavir-boosted lopinavir in HIV-infected individuals who failed initial treatment: a retrospective comparative cohort study. [PDF]

Ann Transl Med, 2022
Chen L, Dai H, Wang J, Wang M, Ma Y, Ma F, Li C, Bai L, Du L, Tang H.   +9 more
europepmc   +1 more source

Evaluation of the Antioxidant, Anticancer, and Antibacterial Activities of Flower and Leaf Extracts of Chrysanthemum indicum

ChemistryOpen, EarlyView.
The tested methanolic extract of Chrysanthemum indicum flower and leaf is a rich source of bioactive molecules with significant antioxidant activity at low doses, potential anticancer effects at lower concentrations, and antimicrobial activities against Gram‐positive and Gram‐negative species, which is consistent with the plant's traditional ...
Tarad Abalkhail, Noorah A. Alkubaisi, Ibrahim M. Aziz, Mashail Fahad Alsayed, Hissah Abdulrahman Alodaini, Amal Saad AL‐Shenifi, Mohamed A. Farrag   +6 more
wiley   +1 more source

Combination Therapy with Indinavir, Ritonavir, and Delavirdine and Nucleoside Reverse Transcriptase Inhibitors in Patients with HIV/AIDS Who Have Failed Multiple Antiretroviral Combinations [PDF]

, 2001
Michael J. Grodesky, Edward P. Acosta, Norman K. Fujita, Susan A. Mason, John G. Gerber   +4 more
openalex   +1 more source

HIV-1 cross-resistance to second-generation non-nucleoside reverse transcriptase inhibitors among individuals failing antiretroviral therapy in Cameroon: implications for the use of long-acting treatment regimens in low- and middle-income countries. [PDF]

JAC Antimicrob Resist
Gouissi Anguechia DH, Bouba Y, Semengue ENJ, Takou D, Chenwi CA, Mekel VK, Beloumou GA, Nka AD, Ka'e AC, Djupsa SCN, Colizzi V, Ndembi N, Ndjolo A, Mbanya D, Perno CF, Fokam J.   +15 more
europepmc   +1 more source

Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients. [PDF]

J Clin Med, 2021
Schultheiss HP, Bock T, Pietsch H, Aleshcheva G, Baumeier C, Fruhwald F, Escher F.   +6 more
europepmc   +1 more source

Clinicopathological and molecular characterization of KRAS wild‐type pancreatic ductal adenocarcinomas reveals precursor lesions with oncogenic mutations and fusions in RAS pathway genes

The Journal of Pathology, EarlyView.
Abstract Pancreatic ductal adenocarcinomas (PDACs) with wild‐type KRAS constitute a small fraction of PDACs, and these tumors were recently shown to harbor frequent actionable oncogenic mutations and fusions. However, the clinicopathological features of KRAS wild‐type PDAC have not been well studied.
Kazuhiro Toriyama, Katsuhiro Masago, Noriko Shibata, Masataka Haneda, Takamichi Kuwahara, Seiji Natsume, Shota Kobayashi, Yasuko Fujita, Eiichi Sasaki, Kenji Yamao, Hiroki Kawashima, Yasuhiro Shimizu, Kazuo Hara, Yasushi Yatabe, Waki Hosoda   +14 more
wiley   +1 more source

Safety Assessment, In Vitro and In Vivo, and Pharmacokinetics of Emivirine, a Potent and Selective Nonnucleoside Reverse Transcriptase Inhibitor of Human Immunodeficiency Virus Type 1

, 2000
George M. Szczech, P A Furman, George R. Painter, David W. Barry, Katyna Borroto–Esoda, Thomas Grizzle, Martin Blum, Jean‐Pierre Sommadossi, RIKA ENDOH, Toshiro Niwa, Momoka Yamamoto, Christopher Moxham   +11 more
openalex   +1 more source

Evaluation of viral resistance to Reverse Transcriptase Inhibitors (RTI) in HIV-1-infected patients before and after 6 months of single or double antiretroviral therapy [PDF]

, 2001
Carlos Brites, Fabianna Bahia, Mark Gilbert, Célia Pedroso, Roberto Badaró   +4 more
openalex   +1 more source